P01-Pathogenesis and Prevention of Osteoporosis

P01-骨质疏松症的发病机制及预防

基本信息

项目摘要

DESCRIPTION OF THE OVERALL PROGRAM (taken from the application): This program project application represents a coordinated, collaborative and multidisciplinary approach that utilizes common resources, facilities and instrumentation to support scientific investigators related to the pathogenesis of osteoporosis. This application is comprised of four highly integrated scientific projects and three supporting core facilities (Administration, Molecular Histology and Transgenic Animal and Molecular Cores). The central theme of the ?program project is that the pathogenesis of osteoporosis is due both to the interaction of catabolic factors that increase bone resorption and to the loss of anabolic activities. These factors, both systemic hormones and local cytokines, modulate the differentiation of osteoclast and osteoblast lineage cells and the biological function of these cells. An understanding of these factors and their actions on bone remodeling will help elucidate the pathogenesis of osteoporosis. Moreover, intervention with molecules that block pathogenic factors or enhance anabolic activities will have therapeutic implications. This could be accomplished by somatic gene therapy once the cellular and molecular steps required to develop such a strategy are developed. The scientific projects of this application are: (1) Glucocorticoids and osteoblast apoptosis, (2) Estrogen regulation of cytokine responsiveness in bone: osteoclastogenesis, (3) The roles of insulin-like growth factor and glucocorticoids on bone remodeling, and (4) Engraftment of osteoprogenitor cells in bone. We believe that interactions among our investigators, research productivity towards the central theme and new collaborations will be facilitated greatly by the program project mechanism.
整体课程描述(取自申请表):本课程

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BARBARA E KREAM其他文献

BARBARA E KREAM的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('BARBARA E KREAM', 18)}}的其他基金

TRANSGENIC EXPRESSION OF 11B-HSD2 IN BONE
11B-HSD2 在骨中的转基因表达
  • 批准号:
    7002749
  • 财政年份:
    2005
  • 资助金额:
    $ 123.06万
  • 项目类别:
TRANSGENIC EXPRESSION OF 11B-HSD2 IN BONE
11B-HSD2 在骨中的转基因表达
  • 批准号:
    7354743
  • 财政年份:
    2005
  • 资助金额:
    $ 123.06万
  • 项目类别:
TRANSGENIC EXPRESSION OF 11B-HSD2 IN BONE
11B-HSD2 在骨中的转基因表达
  • 批准号:
    6873615
  • 财政年份:
    2005
  • 资助金额:
    $ 123.06万
  • 项目类别:
TRANSGENIC EXPRESSION OF 11B-HSD2 IN BONE
11B-HSD2 在骨中的转基因表达
  • 批准号:
    7169799
  • 财政年份:
    2005
  • 资助金额:
    $ 123.06万
  • 项目类别:
EFFECTS OF GLUCOCORTICOIDS AND IGF 1 ON BONE FORMATION
糖皮质激素和 IGF 1 对骨形成的影响
  • 批准号:
    6338654
  • 财政年份:
    2000
  • 资助金额:
    $ 123.06万
  • 项目类别:
PARATHYROID HORMONE INDUCED ICER IN BONE
甲状旁腺激素引起的骨冰
  • 批准号:
    6628103
  • 财政年份:
    2000
  • 资助金额:
    $ 123.06万
  • 项目类别:
PARATHYROID HORMONE INDUCED ICER IN BONE
甲状旁腺激素引起的骨冰
  • 批准号:
    6497417
  • 财政年份:
    2000
  • 资助金额:
    $ 123.06万
  • 项目类别:
PARATHYROID HORMONE INDUCED ICER IN BONE
甲状旁腺激素引起的骨冰
  • 批准号:
    6349977
  • 财政年份:
    2000
  • 资助金额:
    $ 123.06万
  • 项目类别:
PARATHYROID HORMONE INDUCED ICER IN BONE
甲状旁腺激素引起的骨冰
  • 批准号:
    6042095
  • 财政年份:
    2000
  • 资助金额:
    $ 123.06万
  • 项目类别:
PARATHYROID HORMONE INDUCED ICER IN BONE
甲状旁腺激素引起的骨冰
  • 批准号:
    6699032
  • 财政年份:
    2000
  • 资助金额:
    $ 123.06万
  • 项目类别:

相似海外基金

Virtual Mouse and Human Twins for optimising Treatments for Osteoporosis
虚拟小鼠和人类双胞胎用于优化骨质疏松症的治疗
  • 批准号:
    EP/Z000203/1
  • 财政年份:
    2024
  • 资助金额:
    $ 123.06万
  • 项目类别:
    Research Grant
Optimizing osteoporosis diagnosis through opportunistic computed tomography: developing an implementation strategy for early detection and intervention.
通过机会性计算机断层扫描优化骨质疏松症诊断:制定早期检测和干预的实施策略。
  • 批准号:
    484646
  • 财政年份:
    2023
  • 资助金额:
    $ 123.06万
  • 项目类别:
    Fellowship Programs
Center of Research Translation on Osteoporosis Bone Anabolic Therapies
骨质疏松症骨合成代谢疗法研究转化中心
  • 批准号:
    10404412
  • 财政年份:
    2023
  • 资助金额:
    $ 123.06万
  • 项目类别:
Optimizing Small Molecule Mechanomimetics to Treat Age-related Osteoporosis.
优化小分子力学模拟治疗与年龄相关的骨质疏松症。
  • 批准号:
    10807685
  • 财政年份:
    2023
  • 资助金额:
    $ 123.06万
  • 项目类别:
Leveraging a large cohort of patients with a unique, frequent renal sodium phosphate cotransporter, SLC34A3, pathogenic variation to understand and treat osteoporosis and kidney stones
利用大量具有独特、频繁的肾磷酸钠协同转运蛋白 SLC34A3 和致病变异的患者来了解和治疗骨质疏松症和肾结石
  • 批准号:
    494218
  • 财政年份:
    2023
  • 资助金额:
    $ 123.06万
  • 项目类别:
    Operating Grants
Exploring therapeutic effects of anti-inflammatory and resolving factors in osteoporosis model mice
探讨抗炎和缓解因子对骨质疏松模型小鼠的治疗作用
  • 批准号:
    23K15705
  • 财政年份:
    2023
  • 资助金额:
    $ 123.06万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Earlier identification and enhanced characterisation/quantification of Osteoporosis and Rheumatoid Arthritis for Clinics/MIU/ED/CDCs [“DT-RHU”]
诊所/MIU/ED/CDC 的骨质疏松症和类风湿关节炎的早期识别和增强表征/量化 [âDT-RHUâ]
  • 批准号:
    10068051
  • 财政年份:
    2023
  • 资助金额:
    $ 123.06万
  • 项目类别:
    Collaborative R&D
Prevention of osteoporosis through early monitoring of multiple measures of bone health in one device
通过在一台设备中早期监测多种骨骼健康指标来预防骨质疏松症
  • 批准号:
    EP/X000958/1
  • 财政年份:
    2023
  • 资助金额:
    $ 123.06万
  • 项目类别:
    Research Grant
Functional analysis of bone macrophages that control bone metabolism for the development of therapeutic drugs for osteoporosis.
控制骨代谢的骨巨噬细胞的功能分析,用于开发骨质疏松症治疗药物。
  • 批准号:
    23H03025
  • 财政年份:
    2023
  • 资助金额:
    $ 123.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Elucidating the role of NAD+ metabolism in osteoporosis
阐明 NAD 代谢在骨质疏松症中的作用
  • 批准号:
    23K19447
  • 财政年份:
    2023
  • 资助金额:
    $ 123.06万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了